A Swedish nationwide prospective study suggests that adding conventional DMARDs (such as sulfasalazine or methotrexate) to anti-TNF therapy may help spondyloarthritis patients remain longer on the anti-TNF medication they are taking.
By Elin Aslanyan
Research presented at the annual meeting of the European League Against Rheumatism (EULAR 2015) in Rome suggests that physical trauma greatly increases the risk of developing psoriatic arthritis (PsA) in those with psoriasis.
A study presented at the European League Against Rheumatism's (EULAR) 2015 Annual Scientific Meeting suggests that “DNA methylation - a mechanism that regulates gene expression - could influence the progression of structural damage to the joints and spine in ankylosing spondylitis (AS).
Decisions are being made about which medicine you have access to. It's not based on science. It's not based on evidence. It's not your doctor's decision. You do have a choice. Your choice is 'take it or leave it.'
Visit our careers page for available positions
16360 Roscoe Blvd. Ste. 100Van Nuys, CA 91406
(800) 777-8189 U.S. only
or (818) 892-1616*Please note: This is not a Crisis Hotline. If you are in a life-threatening crisis, please dial 911 for immediate help in the US. Please follow this link for crisis intervention resources.